|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 17 3093-3101, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
ER Sharlow, CS Paine, L Babiarz, M Eisinger, S Shapiro and M Seiberg
Johnson & Johnson-Consumer Products Worldwide, Skin Research Center, Skillman, NJ 08558, USA.
The protease-activated receptor-2 (PAR-2) belongs to the family of seven transmembrane domain receptors, which are activated by the specific enzymatic cleavage of their extracellular amino termini. Synthetic peptides corresponding to the tethered ligand domain (SLIGRL in mouse, SLIGKV in human) can activate PAR-2 without the need for receptor cleavage. PAR-2 activation is involved in cell growth, differentiation and inflammatory processes, and was shown to affect melanin and melanosome ingestion by human keratinocytes. Data presented here suggest that PAR-2 activation may regulate human keratinocyte phagocytosis. PAR-2 activation by trypsin, SLIGRL or SLIGKV increased the ability of keratinocytes to ingest fluorescently labeled microspheres or E. coli K-12 bioparticles. This PAR-2 mediated increase in keratinocyte phagocytic capability correlated with an increase in actin polymerization and *-actinin reorganization, cell surface morphological changes and increased soluble protease activity. Moreover, addition of serine protease inhibitors downmodulated both the constitutive and the PAR-2 mediated increases in phagocytosis, suggesting that serine proteases mediate this functional activity in keratinocytes. PAR-2 involvement in keratinocyte phagocytosis is a novel function for this receptor.
This article has been cited by other articles:
|
|
 |
|
  T. J. Moraes, R. Martin, J. D. Plumb, E. Vachon, C. M. Cameron, A. Danesh, D. J. Kelvin, W. Ruf, and G. P. Downey Role of PAR2 in murine pulmonary pseudomonal infection Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L368 - L377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yoshida, A. Hachiya, P. Sriwiriyanont, A. Ohuchi, T. Kitahara, Y. Takema, M. O. Visscher, and R. E. Boissy Functional analysis of keratinocytes in skin color using a human skin substitute model composed of cells derived from different skin pigmentation types FASEB J, September 1, 2007; 21(11): 2829 - 2839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bijl and C. G. Kallenberg Ultraviolet light and cutaneous lupus Lupus, November 1, 2006; 15(11): 724 - 727. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response Endocr. Rev., February 1, 2005; 26(1): 1 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. OSSOVSKAYA and N. W. BUNNETT Protease-Activated Receptors: Contribution to Physiology and Disease Physiol Rev, April 1, 2004; 84(2): 579 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Uehara, S. Sugawara, K. Muramoto, and H. Takada Activation of Human Oral Epithelial Cells by Neutrophil Proteinase 3 Through Protease-Activated Receptor-2 J. Immunol., October 15, 2002; 169(8): 4594 - 4603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Scott, S. Leopardi, S. Printup, and B. C. Madden Filopodia are conduits for melanosome transfer to keratinocytes J. Cell Sci., January 4, 2002; 115(7): 1441 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282. [Abstract] [Full Text] [PDF]
|
|
